한글목차

돼지 백신 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 23억 7,000만 달러에서 2026년에는 26억 달러로, CAGR 9.5%로 확대할 전망입니다. 지난 수년간의 성장은 돼지의 높은 바이러스 및 세균 감염 발생률, 돼지고기 제품에 대한 수요 증가, 상업적 양돈의 확대, 기존 생백신 및 불활화 백신의 개발, 양돈장의 헬스케어에 대한 인식이 높아졌기 때문인 것으로 보입니다.

돼지 백신 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 37억 4,000만 달러에 달하며, CAGR은 9.6%에 달할 전망입니다. 예측 기간 중의 성장은 DNA 백신 및 재조합 백신의 채택, 돼지 백신 접종 프로그램에 대한 정부 지원 강화, 정밀 축산 성장, 신흥 전염병에 대한 관심, 백신 유통을 위한 콜드체인 인프라 확대에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 다가성 돼지 백신 개발, 예방적 돼지 건강관리에 대한 집중, DNA 백신 및 재조합 백신의 발전, 콜드체인 최적화를 통한 백신 유통, 신흥 돼지 질병에 대한 신속한 대응 백신 등이 있습니다.

향후 수년간 돼지의 질병 발생률 증가가 돼지 백신 시장의 성장을 촉진할 것으로 예측됩니다. 돼지 질병은 가성 광견병, 인플루엔자 등의 질병을 포함하여 증상을 동반하는 경우가 많은 돼지의 정상적인 구조적, 기능적 상태로부터의 일탈을 말합니다. 동물 밀도를 높이는 집약적 사육방식으로 인해 질병 전파가 가속화되고 발생 통제가 어려워져 돼지 질병 발생률은 증가 추세에 있습니다. 돼지 백신은 면역체계를 자극하여 특정 병원체를 인식하고 반응하게 함으로써 이 문제에 대응할 수 있도록 돕습니다. 이를 통해 감염률 감소, 질병 중증도 완화, 집단 전체의 건강 증진을 촉진할 수 있습니다. 예를 들어 미국에 본부를 둔 돼지 건강 정보 센터(SHIC)에 따르면 2023년 12월 현재 폴란드의 야생 멧돼지 아프리카돼지열병(ASF) 발병 건수가 우려할 만큼 증가하여 2023년 초에 2,347건의 확진 사례가 기록되며, 2022년의 총 발병 건수를 넘어섰다고 합니다. 총 발생 건수를 넘어섰습니다. 따라서 돼지 질병의 확산이 시장 성장을 가속할 것으로 예측됩니다.

돼지 백신 시장의 주요 기업은 경쟁 우위를 강화하기 위해 서캄벤트 CML과 같은 혁신적인 백신 개발에 집중하고 있습니다. 써컴벤트 CML은 여러 질병으로부터 돈군을 보호하고 전반적인 건강 상태와 생산성을 향상시키기 위해 고안된 제품입니다. 예를 들어 2023년 6월 미국 제약사 머크 동물 건강(Merck Animal Health)는 3종 혼합 돼지 백신 '서캄벤트 CML'을 출시했습니다. 본 백신은 돼지 써코바이러스 2a형(PCV-2a), 돼지 써코바이러스 2d형(PCV-2d), 마이코플라즈마 하이오뉴모니아, 로소니아 인트라셀룰라리스에 대한 방어 효과가 있습니다. 이 백신은 머크가 기존에 확립한 항원 및 보조제 기술을 기반으로 하고 있으며, 이미 '서캄벤트 PCV-M G2' 및 단독 제품인 '포실리스 이레이티스'에 사용되고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A swine vaccine is a formulation given or injected into pigs to provoke an immune response against a particular infectious agent. These vaccines play a vital role in preventing diseases that can adversely affect pig health, productivity, and overall herd management.

The primary types of swine vaccines include attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines consist of weakened living viruses or bacteria that have been altered to reduce their pathogenicity. These vaccines aim to trigger a robust immune response in pigs by replicating within the body, leading to prolonged immunity. They are effective against various diseases including viral, bacterial, parasitic, and fungal infections. Swine vaccines are distributed through veterinary hospitals, veterinary pharmacies, and online pharmacies. These products are available through government tenders and sales in the market.

Tariffs have affected the swine vaccines market by increasing the cost of imported vaccine components, plasmid DNA, and recombinant technology kits, causing delays and supply chain disruptions. Regions like North America and Europe, with heavy reliance on imported advanced vaccines, are most impacted, particularly in commercial pig farms and veterinary hospitals. Positively, tariffs incentivize local vaccine manufacturing, encourage development of cost-efficient vaccine solutions, and enhance domestic production capabilities.

The swine vaccines market research report is one of a series of new reports from The Business Research Company that provides swine vaccines market statistics, including swine vaccines industry global market size, regional shares, competitors with a swine vaccines market share, detailed swine vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the swine vaccines industry. This swine vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The swine vaccines market size has grown strongly in recent years. It will grow from $2.37 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to high incidence of viral and bacterial infections in swine, increasing demand for pork products, expansion of commercial pig farming, development of conventional live and inactivated vaccines, rising awareness of swine herd health management.

The swine vaccines market size is expected to see strong growth in the next few years. It will grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to adoption of dna and recombinant vaccines, increasing government support for swine vaccination programs, growth in precision livestock farming, focus on emerging infectious diseases, expansion of cold-chain infrastructure for vaccine distribution. Major trends in the forecast period include development of multi-valent swine vaccines, focus on preventive swine healthcare, advancements in dna and recombinant vaccines, cold-chain optimized vaccine distribution, rapid response vaccines for emerging swine diseases.

The rising prevalence of diseases in swine is expected to drive the growth of the swine vaccine market in the coming years. Swine diseases refer to any deviations from normal structural or functional conditions in pigs, often accompanied by symptoms, including illnesses such as pseudorabies and influenza. The incidence of swine diseases is increasing due to intensive farming practices that raise animal density, accelerating disease transmission and making outbreaks more difficult to control. Swine vaccines help address this challenge by stimulating the immune system to recognize and respond to specific pathogens, thereby reducing infection rates, mitigating disease severity, and promoting overall herd health. For example, in December 2023, according to the Swine Health Information Center, a US-based organization, Poland reported a concerning rise in African Swine Fever (ASF) cases among wild boars, with 2,347 confirmed cases recorded in early 2023, exceeding the total for 2022. Therefore, the increasing prevalence of swine diseases is expected to propel market growth.

Leading players in the swine vaccine market are focusing on developing innovative vaccines, such as Circumvent CML, to strengthen their competitive position. Circumvent CML is designed to protect swine herds against multiple diseases, enhancing overall health and productivity. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company, launched the 3-in-1 swine vaccine Circumvent CML, which protects against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. The vaccine builds on Merck's established antigens and adjuvant systems previously used in Circumvent PCV-M G2 and the standalone Porcilis Ileitis product.

In July 2024, MSD Animal Health, a US-based biopharmaceutical company, acquired Elanco's aqua business for $1.3 billion. Through this acquisition, MSD Animal Health aims to strengthen its presence in the aquaculture sector by expanding its portfolio of products and solutions that support fish health, welfare, and sustainability. Elanco is a US-based pharmaceutical company specializing in swine vaccine solutions.

Major companies operating in the swine vaccines market are Merck & Co Inc., Boehringer Ingelheim Animal Health USA Inc., Elanco Animal Health Inc., Biogenesis Bago SA, Phibro Animal Health Corporation, KM Biologics Co. Ltd., Hipra Laboratories SA, Ceva Sante Animale SA, Zoetis Inc., Jinyu Bio-Technology Co. Ltd., China Animal Husbandry Industry Co. Ltd., Virbac SA, Harbin Veterinary Research Institute, Bioveta AS, Bimeda Holdings PLC, Biovac Ltd., Hester Biosciences Limited, Hygieia Biological Laboratories, IDT Biologika GmbH, Intervet Inc., Komipharm International Co. Ltd., Kyoritsu Seiyaku Corporation, Lohmann Animal Health International, Norbrook Laboratories Limited, Ouro Fino Saude Animal SA, Prondil SA, Vaxxinova International BV, Vetoquinol SA, Veyx Pharma GmbH, Tianjin Ringpu Bio-Technology Co. Ltd.

North America was the largest region in the swine vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the swine vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The swine vaccine market consists of sales of haemophilus parasuis, pasteurella, salmonella, and streptococcus suis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Swine Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses swine vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for swine vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The swine vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Attenuated Live Vaccines; Inactivated Vaccines; Subunit Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Recombinant Vaccines
• 2) By Disease: Viral Infections; Bacterial Infections; Parasitic Infection; Fungal Infections; Other Diseases
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Pharmacies; Online Pharmacies
• 4) By Application: Government Tender; Market Sales
• Subsegments:
• 1) By Attenuated Live Vaccines: Live Attenuated Virus Vaccines; Live Attenuated Bacterial Vaccines
• 2) By Inactivated Vaccines: Whole Inactivated Virus Vaccines; Inactivated Bacterial Vaccines
• 3) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Subunit Vaccines
• 4) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines; Nucleic Acid Vaccines
• 5) By Recombinant Vaccines: Recombinant Vector Vaccines; Recombinant Protein Vaccines
• Companies Mentioned: Merck & Co Inc.; Boehringer Ingelheim Animal Health USA Inc.; Elanco Animal Health Inc.; Biogenesis Bago SA; Phibro Animal Health Corporation; KM Biologics Co. Ltd.; Hipra Laboratories SA; Ceva Sante Animale SA; Zoetis Inc.; Jinyu Bio-Technology Co. Ltd.; China Animal Husbandry Industry Co. Ltd.; Virbac SA; Harbin Veterinary Research Institute; Bioveta AS; Bimeda Holdings PLC; Biovac Ltd.; Hester Biosciences Limited; Hygieia Biological Laboratories; IDT Biologika GmbH; Intervet Inc.; Komipharm International Co. Ltd.; Kyoritsu Seiyaku Corporation; Lohmann Animal Health International; Norbrook Laboratories Limited; Ouro Fino Saude Animal SA; Prondil SA; Vaxxinova International BV; Vetoquinol SA; Veyx Pharma GmbH; Tianjin Ringpu Bio-Technology Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Swine Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Swine Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Swine Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Swine Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Development Of Multi-Valent Swine Vaccines
  • 4.2.2 Focus On Preventive Swine Healthcare
  • 4.2.3 Advancements In Dna And Recombinant Vaccines
  • 4.2.4 Cold-Chain Optimized Vaccine Distribution
  • 4.2.5 Rapid Response Vaccines For Emerging Swine Diseases

5. Swine Vaccines Market Analysis Of End Use Industries

• 5.1 Commercial Pig Farms
• 5.2 Veterinary Hospitals
• 5.3 Veterinary Pharmacies
• 5.4 Swine Research Centers
• 5.5 Government Veterinary Programs

6. Swine Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Swine Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Swine Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Swine Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Swine Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Swine Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Swine Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Swine Vaccines Market Segmentation

• 9.1. Global Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines
• 9.2. Global Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases
• 9.3. Global Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies
• 9.4. Global Swine Vaccines Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Government Tender, Market Sales
• 9.5. Global Swine Vaccines Market, Sub-Segmentation Of Attenuated Live Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Virus Vaccines, Live Attenuated Bacterial Vaccines
• 9.6. Global Swine Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
• 9.7. Global Swine Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
• 9.8. Global Swine Vaccines Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Plasmid DNA Vaccines, Nucleic Acid Vaccines
• 9.9. Global Swine Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Recombinant Vector Vaccines, Recombinant Protein Vaccines

10. Swine Vaccines Market Regional And Country Analysis

• 10.1. Global Swine Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Swine Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Swine Vaccines Market

• 11.1. Asia-Pacific Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Swine Vaccines Market

• 12.1. China Swine Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Swine Vaccines Market

• 13.1. India Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Swine Vaccines Market

• 14.1. Japan Swine Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Swine Vaccines Market

• 15.1. Australia Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Swine Vaccines Market

• 16.1. Indonesia Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Swine Vaccines Market

• 17.1. South Korea Swine Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Swine Vaccines Market

• 18.1. Taiwan Swine Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Swine Vaccines Market

• 19.1. South East Asia Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Swine Vaccines Market

• 20.1. Western Europe Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Swine Vaccines Market

• 21.1. UK Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Swine Vaccines Market

• 22.1. Germany Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Swine Vaccines Market

• 23.1. France Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Swine Vaccines Market

• 24.1. Italy Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Swine Vaccines Market

• 25.1. Spain Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Swine Vaccines Market

• 26.1. Eastern Europe Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Swine Vaccines Market

• 27.1. Russia Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Swine Vaccines Market

• 28.1. North America Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Swine Vaccines Market

• 29.1. USA Swine Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Swine Vaccines Market

• 30.1. Canada Swine Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Swine Vaccines Market

• 31.1. South America Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Swine Vaccines Market

• 32.1. Brazil Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Swine Vaccines Market

• 33.1. Middle East Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Swine Vaccines Market

• 34.1. Africa Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Swine Vaccines Market, Segmentation By Product, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Swine Vaccines Market Regulatory and Investment Landscape

36. Swine Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Swine Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Swine Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Swine Vaccines Market Company Profiles
  • 36.3.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Boehringer Ingelheim Animal Health USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Biogenesis Bago SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Phibro Animal Health Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Swine Vaccines Market Other Major And Innovative Companies

• KM Biologics Co. Ltd., Hipra Laboratories SA, Ceva Sante Animale SA, Zoetis Inc., Jinyu Bio-Technology Co. Ltd., China Animal Husbandry Industry Co. Ltd., Virbac SA, Harbin Veterinary Research Institute, Bioveta AS, Bimeda Holdings PLC, Biovac Ltd., Hester Biosciences Limited, Hygieia Biological Laboratories, IDT Biologika GmbH, Intervet Inc.

38. Global Swine Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Swine Vaccines Market

40. Swine Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Swine Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Swine Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Swine Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer